FULC
Fulcrum Therapeutics Inc
Price:  
6.93 
USD
Volume:  
381,941.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FULC EV/EBITDA

-107.8%
Upside

As of 2025-07-03, the EV/EBITDA ratio of Fulcrum Therapeutics Inc (FULC) is -53.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FULC's latest enterprise value is 331.90 mil USD. FULC's TTM EBITDA according to its financial statements is -6.20 mil USD. Dividing these 2 quantities gives us the above FULC EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.3x - 10.3x 8.2x
Forward P/E multiples 11.3x - 17.7x 14.8x
Fair Price (0.51) - (0.40) (0.54)
Upside -107.4% - -105.7% -107.8%
6.93 USD
Stock Price
(0.54) USD
Fair Price

FULC EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-02 -53.58
2025-07-01 -52.79
2025-06-30 -53.14
2025-06-27 -55.06
2025-06-26 -57.50
2025-06-25 -55.58
2025-06-24 -55.84
2025-06-23 -55.67
2025-06-20 -54.14
2025-06-18 -48.61
2025-06-17 -49.22
2025-06-16 -52.44
2025-06-13 -52.88
2025-06-12 -52.27
2025-06-11 -52.70
2025-06-10 -53.31
2025-06-09 -55.23
2025-06-06 -56.36
2025-06-05 -55.14
2025-06-04 -54.45
2025-06-03 -54.49
2025-06-02 -53.84
2025-05-30 -53.10
2025-05-29 -54.80
2025-05-28 -53.31
2025-05-27 -48.52
2025-05-23 -49.31
2025-05-22 -46.52
2025-05-21 -47.65
2025-05-20 -49.92
2025-05-19 -53.58
2025-05-16 -53.14
2025-05-15 -50.70
2025-05-14 -42.25
2025-05-13 -43.64
2025-05-12 -42.68
2025-05-09 -39.98
2025-05-08 -40.33
2025-05-07 -37.37
2025-05-06 -39.81
2025-05-05 -43.12
2025-05-02 -42.16
2025-05-01 -31.36
2025-04-30 -26.74
2025-04-29 -25.00
2025-04-28 -24.30
2025-04-25 -23.95
2025-04-24 -23.78
2025-04-23 -24.47
2025-04-22 -25.00